AU2001258938A1 - Chimeric arterivirus-like particles - Google Patents

Chimeric arterivirus-like particles

Info

Publication number
AU2001258938A1
AU2001258938A1 AU2001258938A AU5893801A AU2001258938A1 AU 2001258938 A1 AU2001258938 A1 AU 2001258938A1 AU 2001258938 A AU2001258938 A AU 2001258938A AU 5893801 A AU5893801 A AU 5893801A AU 2001258938 A1 AU2001258938 A1 AU 2001258938A1
Authority
AU
Australia
Prior art keywords
arterivirus
particles
structural protein
chimeric
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258938A
Other languages
English (en)
Inventor
Johanna Jacoba Maria Meulenberg
Monique Helene Verheije
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Lelystad Instituut voor Dierhouderij en Diergezondheid BV
Original Assignee
ID Lelystad Instituut voor Dierhouderij en Diergezondheid BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID Lelystad Instituut voor Dierhouderij en Diergezondheid BV filed Critical ID Lelystad Instituut voor Dierhouderij en Diergezondheid BV
Publication of AU2001258938A1 publication Critical patent/AU2001258938A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10023Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10061Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001258938A 2000-05-19 2001-05-21 Chimeric arterivirus-like particles Abandoned AU2001258938A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00201780A EP1156111A1 (en) 2000-05-19 2000-05-19 Chimeric arterivirus-like particles
EP00201780 2000-05-19
PCT/NL2001/000382 WO2001090363A1 (en) 2000-05-19 2001-05-21 Chimeric arterivirus-like particles

Publications (1)

Publication Number Publication Date
AU2001258938A1 true AU2001258938A1 (en) 2001-12-03

Family

ID=8171523

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258938A Abandoned AU2001258938A1 (en) 2000-05-19 2001-05-21 Chimeric arterivirus-like particles

Country Status (14)

Country Link
US (1) US7122347B2 (pt)
EP (2) EP1156111A1 (pt)
JP (1) JP4875274B2 (pt)
KR (1) KR100916883B1 (pt)
AT (1) ATE426026T1 (pt)
AU (1) AU2001258938A1 (pt)
CA (1) CA2409209C (pt)
CY (1) CY1109141T1 (pt)
DE (1) DE60138014D1 (pt)
DK (1) DK1283887T3 (pt)
ES (1) ES2322237T3 (pt)
MX (1) MXPA02011415A (pt)
PT (1) PT1283887E (pt)
WO (1) WO2001090363A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224327A1 (en) * 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
CA2366072C (en) 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
JP4778620B2 (ja) 1999-04-22 2011-09-21 ユナイテッド ステイツ デパートメント オブ アグリカルチャー 分離株ja−142に基づく、豚繁殖・呼吸障害症候群ワクチン
KR20030082960A (ko) * 2001-03-09 2003-10-23 베링거잉겔하임베트메디카게엠베하 Prrs 바이러스의 약독화된 생균 균주
EP1438969A1 (en) * 2003-01-14 2004-07-21 Universiteit Utrecht Arterivirus marker vaccine
RU2007101725A (ru) 2004-06-18 2008-07-27 Риджентс Оф Дзе Юниверсити Оф Миннесота (Us) Идентификация инфицированных вирусом и вакцинированных вирусом организмов
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
DK2369001T3 (en) 2005-06-24 2016-10-24 Univ Minnesota PRRS viruses, infectious clones, mutants thereof and methods of use
US9216212B2 (en) * 2005-08-05 2015-12-22 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US7951384B2 (en) * 2005-08-05 2011-05-31 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
CA2630648C (en) * 2005-11-29 2016-01-19 Iowa State University Research Foundation, Inc. Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof
TW201605471A (zh) * 2007-04-30 2016-02-16 Mj生物股份有限公司 豬繁殖與呼吸道症候群病毒(prrsv)gp5爲主之組成物及方法
US7666585B2 (en) * 2007-06-15 2010-02-23 Protatek International, Inc. Construction of chimera PRRSV, compositions and vaccine preparations
EP2328612A4 (en) * 2008-08-25 2012-11-14 Boehringer Ingelheim Vetmed VACCINE AGAINST HIGH PATHOGENIC DISEASED LATE LIVESTOCK (PRRS)
US8580270B2 (en) * 2008-09-30 2013-11-12 University Of Massachusetts Respiratory synctial virus (RSV) sequences for protein expression and vaccines
EP2230246A1 (en) * 2009-03-19 2010-09-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Arterivirus glycoprotein 5 virus-like particles
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
BR112013021076B1 (pt) 2011-02-17 2022-11-29 Boehringer Ingelheim Vetmedica Gmbh Vírus da síndrome respiratória e reprodutiva suína (prrsv) de um tipo europeu, seu uso, vacina, método para a preparação destes
CA2827337C (en) 2011-02-17 2019-07-09 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
WO2013017568A1 (en) 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
CN102908617A (zh) * 2011-08-04 2013-02-06 广州格拉姆生物科技有限公司 一种猪繁殖与呼吸综合症病毒m蛋白与cd40l融合疫苗及制备方法
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
DK3591042T3 (da) 2013-12-20 2023-04-17 Boehringer Ingelheim Vetmedica Gmbh PRRS-virusvariant, cDNA-klon af europæisk PRRS-virus samt anvendelser deraf
JPWO2016021276A1 (ja) 2014-08-08 2017-05-25 出光興産株式会社 豚繁殖・呼吸障害症候群防除剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2102971B1 (es) * 1996-01-25 1998-03-01 Hipra Lab Sa Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
WO1998055626A2 (en) * 1997-06-05 1998-12-10 Origen, Inc. Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
CA2366072C (en) * 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines

Also Published As

Publication number Publication date
CY1109141T1 (el) 2014-07-02
JP2004506411A (ja) 2004-03-04
ATE426026T1 (de) 2009-04-15
US20030161845A1 (en) 2003-08-28
EP1283887B1 (en) 2009-03-18
EP1156111A1 (en) 2001-11-21
EP1283887A1 (en) 2003-02-19
KR20030026931A (ko) 2003-04-03
WO2001090363A1 (en) 2001-11-29
JP4875274B2 (ja) 2012-02-15
KR100916883B1 (ko) 2009-09-09
CA2409209C (en) 2011-08-09
MXPA02011415A (es) 2004-02-26
DE60138014D1 (de) 2009-04-30
CA2409209A1 (en) 2001-11-29
DK1283887T3 (da) 2009-06-22
US7122347B2 (en) 2006-10-17
ES2322237T3 (es) 2009-06-18
PT1283887E (pt) 2009-03-31

Similar Documents

Publication Publication Date Title
AU2001258938A1 (en) Chimeric arterivirus-like particles
WO2001098333A3 (en) Modification of hepatitis b core antigen
FR20C1016I1 (pt)
AU7545801A (en) Chimeric human papillomavirus (hpv) l1 molecules and uses therefor
WO2002007742A8 (en) Bacteriophage having multiple host range
AU9498098A (en) Buffers for stabilizing antigens
EP1354034B8 (en) Transgenic transchromosomal rodents for making human antibodies
DK0757717T3 (da) Papillomavirusvacciner
AU1199900A (en) Use of purified invaplex from gram negative bacteria as a vaccine
AU2001282528A1 (en) Compounds having anti-hepatitis c virus effect
MY126238A (en) Crystalline composition containing escitalopram
EP1305438A4 (en) IMPROVED VIRUS-SIMILAR PARTICLES BUILDING ON THE HEPATITIS B SMALL SLEEP PROTEIN
HK1061201A1 (en) Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
MXPA03009541A (es) Desviador de flujo y soplante de exhaustacion para un montaje separador de tamiz vibratorio.
DE69939555D1 (de) Granuliertes Brotverbesserungmittel zur Herstellung von Teigwaren
AU2002220460A1 (en) The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
WO2002004495A3 (en) Streptococcus pyogenes antigen
WO2007016715A3 (en) Immune response inducing preparations
AU2002362761A1 (en) Generation of virus-like particles by vsv
EP1451338B8 (en) Recombinant antibodies for the detection and neutralization of anthrax toxin
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
ES2168918A1 (es) Dispositivo abocinado de un acondicionador de aire del techo.
AU2002257890A1 (en) Method for replicating the hepatitis C virus
AU2002221276A1 (en) Insulator of particles created between the articulating components of artificialjoints
AU2002219110A1 (en) Cooking device